A. Ponzoni et al., THE EFFECTS OF SELECTIVE ACTIVATION OF THE 5-HT3 RECEPTOR WITH M-CHLOROPHENYLBIGUANIDE ON SLEEP AND WAKEFULNESS IN THE RAT, European journal of pharmacology, 249(3), 1993, pp. 259-264
The effects of the 5-HT3 receptor agonist, m-chlorophenylbiguanide, we
re compared with those of the 5-HT3 receptor antagonist, MDL 72222, in
rats implanted with electrodes for chronic sleep recordings. m-Chloro
phenylbiguanide (12.5-50.0 mu g) injected into the left lateral ventri
cle increased wakefulness and rapid eye movement (REM) sleep latency,
whereas slow wave sleep, REM sleep and the number of REM periods were
reduced. MDL 72222 (0.1-1.0 mg/kg, s.c.) induced a delayed and dose-de
pendent increase of slow wave sleep. Pretreatment with MDL 72222 (0.1-
0.5 mg/kg) prevented the effects of m-chlorophenylbiguanide (50 mu g)
on wakefulness and sleep. It is suggested that the increase of wakeful
ness after 5-HT3 receptor activation could be related to the release o
f endogenous serotonin and dopamine.